Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Artificial Intelligence-assisted cardiovascular risk stratification for supporting therapeutic decision-making

L Babitha1 , Krishnan K Sundara2

1United Institute of Technology, Coimbatore,; 2Department of Computer Science and Engineering, Alagappa Chettiar Government College of Engineering and Technology, Karaikudi, India.

For correspondence:-   Babitha   Email: achsbabi@gmail.com

Received: 2 February 2026        Accepted: 18 April 2026        Published: 30 April 2026

Citation: Babitha L, Sundara KK. Artificial Intelligence-assisted cardiovascular risk stratification for supporting therapeutic decision-making. Trop J Pharm Res 2026; 25(4):581-591 doi: https://dx.doi.org/10.4314/tjpr.v25i4.15

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To apply Hybrid Feature Deep Learning (HFEDL) and structured feature-selection framework (Selected Features) model to develop algorithm for enhanced preventive cardiovascular disease risk prediction. Methods: The HFEDL model is a hybrid feature-engineering and deep-learning method that improves learning dynamics, whereas the structured feature-selection framework is based on statistically significant features to achieve higher classification accuracy. Benchmark datasets have been used to compare various models, including traditional deep learning and the random forest classifier. Results: The HFEDL model achieved 97.5 % testing accuracy and 0.2 loss, the quickest convergence period (15 epochs), and generalization. The structured feature-selection framework model was also able to achieve 90.8 %, and the model had a steady performance. The models generated significant outcomes that were better in terms of accuracy, training efficiency, and generalization (5/5) when compared to traditional state-of-the-art models; thus, the models may be considered to offer real-time clinical decision support. The predicted risk levels support therapeutic decision-making by guiding pharmacological interventions such as statins, antihypertensive therapy, and patient monitoring strategies. Conclusion: The HFEDL model has better predictive capability than traditional machine learning and isolated deep learning models, and the feature-selection framework is more interpretable and less complex to calculate because it identifies clinically meaningful variables. Combining feature selection with hybrid deep learning constitutes a trade-off between accuracy, efficiency, and interpretability.

Keywords: Feature Selection, Random Forest Classification, Hybrid Feature Enriched Deep Learning

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: